The company has demonstrably boosted the development of a novel treatment for amyloid heart disease, employing the compound. Early clinical data suggests potential improvements for patients diagnosed by a debilitating https://attr-cm613709.bloggosite.com/50116085/bridgebio-progresses-attr-cm-treatment-through-the-therapy